摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl (2-((3-(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)propyl)amino)-2-oxoethyl)(benzyl)carbamate | 1186302-05-5

中文名称
——
中文别名
——
英文名称
tert-butyl (2-((3-(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)propyl)amino)-2-oxoethyl)(benzyl)carbamate
英文别名
——
tert-butyl (2-((3-(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)propyl)amino)-2-oxoethyl)(benzyl)carbamate化学式
CAS
1186302-05-5
化学式
C29H39N3O4
mdl
——
分子量
493.646
InChiKey
KJDRNQLBBGEVPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.45
  • 重原子数:
    36.0
  • 可旋转键数:
    8.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    71.11
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl (2-((3-(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)propyl)amino)-2-oxoethyl)(benzyl)carbamate三氟乙酸 、 sodium hydroxide 作用下, 以 为溶剂, 反应 1.0h, 以100%的产率得到2-benzylamino-N-{3-[spiro(isobenzofuran-1(3H),4'-piperidine)-1'-yl]propyl}acetamide
    参考文献:
    名称:
    Structure–activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide
    摘要:
    Twelve derivatives of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide (Comp 24) were synthesised and tested in binding experiments performed on CHOhNOP cell membranes. Among them, a novel interesting NOP receptor antagonist (compound 35) was identified by blending chemical moieties taken from different NOP receptor ligands. In vitro in various assays, Compound 35 consistently behaved as a pure, highly potent (pA(2) in the range 8.0-9.9), competitive and NOP selective antagonist. However compound 35 was found inactive when challenged against N/OFQ in vivo in the mouse tail withdrawal assay. Thus the usefulness of the novel NOP ligand compound 35 is limited to in vitro investigations. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.05.068
  • 作为产物:
    描述:
    N-[(1,1-二甲基乙氧基)羰基]-N-(苯基甲基)-甘氨酸3-spiro[isobenzofuran-1(3H),4'-piperidine]-1-ylpropane-1-amine1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 24.17h, 以22%的产率得到tert-butyl (2-((3-(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)propyl)amino)-2-oxoethyl)(benzyl)carbamate
    参考文献:
    名称:
    Structure–activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide
    摘要:
    Twelve derivatives of the nociceptin/orphanin FQ (N/OFQ) receptor (NOP) antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide (Comp 24) were synthesised and tested in binding experiments performed on CHOhNOP cell membranes. Among them, a novel interesting NOP receptor antagonist (compound 35) was identified by blending chemical moieties taken from different NOP receptor ligands. In vitro in various assays, Compound 35 consistently behaved as a pure, highly potent (pA(2) in the range 8.0-9.9), competitive and NOP selective antagonist. However compound 35 was found inactive when challenged against N/OFQ in vivo in the mouse tail withdrawal assay. Thus the usefulness of the novel NOP ligand compound 35 is limited to in vitro investigations. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.05.068
点击查看最新优质反应信息